| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SYNTHETIC CONJUGATED ESTROGENS A | 021788 | 001 | NDA | ESTROGENS, CONJUGATED SYNTHETIC A | CREAM;VAGINAL | 0.625MG/GM | No | No | 2008/11/28 | 2008/11/28 | TEVA WOMENS | Discontinued |
| CONJUGATED ESTROGENS | 214023 | 001 | ANDA | ESTROGENS, CONJUGATED | TABLET;ORAL | 0.9MG | No | No | 2025/10/15 | 2025/10/15 | NOVAST LABS | Prescription |
| CONJUGATED ESTROGENS | 214023 | 002 | ANDA | ESTROGENS, CONJUGATED | TABLET;ORAL | 1.25MG | No | No | 2025/10/15 | 2025/10/15 | NOVAST LABS | Prescription |
| CONJUGATED ESTROGENS | 214025 | 001 | ANDA | ESTROGENS, CONJUGATED | TABLET;ORAL | 0.3MG | No | No | 2025/10/15 | 2025/10/15 | NOVAST LABS | Prescription |
| CONJUGATED ESTROGENS | 214025 | 002 | ANDA | ESTROGENS, CONJUGATED | TABLET;ORAL | 0.45MG | No | No | 2025/10/15 | 2025/10/15 | NOVAST LABS | Prescription |
| CONJUGATED ESTROGENS | 214025 | 003 | ANDA | ESTROGENS, CONJUGATED | TABLET;ORAL | 0.625MG | No | No | 2025/10/15 | 2025/10/15 | NOVAST LABS | Prescription |